Vaxart Inc

Vaxart’s oral flu vaccine harnesses gut immunity to deliver a convenient, potentially superior alternative to injections—transforming flu prevention and biotech investing.

Vaxart Inc. has appointed Jeroen Grasman as its new Chief Financial Officer, effective May 19, 2025, as the company navigates financial developments and prepares for future growth.